BURU.AMEXNuburu, INC

S-1: Nuburu Registers 25.9M Shares for Resale by Key Investors

Sentiment:

Resale Registration Statement


Nuburu, Inc. filed an S-1 registration statement for the resale of up to 25,938,157 shares of common stock by various selling stockholders, including major convertible note holders.

Delay expectedThe company was unable to achieve quorum for a stockholder meeting to approve securities issuable upon conversion of August 2024 Convertible Notes, forcing a delay in obtaining approval.The registration statement for the resale of shares issuable on conversion of August 2024 Convertible Notes has not yet been declared effective by the SEC.Entering into a new lease and appropriately equipping a new facility is "costly and time-consuming and may cause delays" in progress with the new business plan.Consummation of the full TCEI acquisition is subject to continued due diligence, acceptable valuation, regulatory approvals, and stockholder consent, which could cause delays.The SYME strategic investment is contingent upon approvals from SYME stockholders, the Financial Conduct Authority, and The Panel on Takeovers and Mergers.The second stage of the Tekne acquisition, requiring stockholder and regulatory approval, is anticipated by the end of 2025, indicating a phased and potentially delayed process.
Capital raiseThe company entered into a Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. on May 30, 2025, for up to $100 million of Common Stock sales over 36 months.The company issued various unsecured convertible promissory notes to Indigo Capital LP, Brick Lane Capital Management Limited, Bomore Opportunity Group Ltd, Torcross Capital LLC, 1800 Diagonal Lending LLC, and Boot Capital LLC, totaling significant capital infusions.Diagonal agreed to provide additional tranches of financing up to an aggregate of $2,275,000 over the next twelve months.The company entered into a convertible facility with Supply@ME Capital Plc (SYME) to loan SYME up to $5.15 million, which upon conversion is expected to result in a controlling interest.The company is assisting with financing up to EUR 40 million for Tekne's working capital needs, through a EUR 10.5 million cash financing (Capital Support) and a EUR 30 million inventory monetization program.The company's Executive Chairman loaned $900,000 of cash proceeds from the TCEI acquisition back to the company for working capital in May 2025.The company issued a promissory note for $545,000 to The AvantGarde Group (TAG), owned by the Executive Chairman, as a replacement for a shareholder advance.The company expects to rely on private and public capital raising efforts to fund operations.
Worse than expectedThe company reported significant net losses ($34.5 million in 2024, $28.8 million in H1 2025) and a growing accumulated deficit ($150.2 million as of June 30, 2025).Revenue declined drastically from $2.08 million in 2023 to $152,127 in 2024, and was nil in H1 2025.The company received a NYSE American Notice of Noncompliance due to low stockholders' equity and recurring losses, indicating financial distress.The company's patent portfolio, a core asset, was foreclosed upon by secured lenders.The company defaulted on its lease, leading to a default judgment and write-down of inventory and property to zero.The company is obligated to redeem preferred stock but lacks legally available funds.The auditor's report includes a going concern qualification.

Summary

  • Nuburu, Inc. (BURU) is registering up to 25,938,157 shares of common stock for resale by selling stockholders, primarily from conversions of unsecured promissory notes.
  • The company will not receive any proceeds from the sale of these shares by the selling stockholders.
  • As of August 20, 2025, the last quoted sale price for Common Stock on NYSE American was $0.1630 per share.
  • The company reported a net loss of $34.5 million for the year ended December 31, 2024, and $28.8 million for the six months ended June 30, 2025.
  • The accumulated deficit reached $150.2 million as of June 30, 2025.
  • Revenue decreased significantly to $152,127 in 2024 from $2.08 million in 2023, and was nil for the six months ended June 30, 2025.
  • The company received a Notice of Noncompliance from NYSE American on April 29, 2025, for not maintaining stockholders' equity of $2.0 million or more, with a compliance deadline of October 29, 2026.
  • The company's patent portfolio was transferred to senior secured lenders in March 2025 in exchange for extinguishing outstanding secured indebtedness.
  • Nuburu is shifting its laser business focus to licensing and joint development within specific verticals, particularly the defense industry, and outsourcing production.
  • The company is pursuing a 'Transformation Plan' involving strategic acquisitions and investments, including a controlling interest in defense-tech company Tekne S.p.A. and a SaaS startup.
  • A Standby Equity Purchase Agreement (SEPA) was entered into with YA II PN, LTD. on May 30, 2025, for up to $100 million in Common Stock sales.
  • The company is obligated to redeem all outstanding Series A Preferred Stock for $10.00 per share as of January 31, 2025, but currently lacks legally available funds.

Sentiment

Score: 2

Explanation: The company faces severe financial challenges, including recurring losses, a substantial accumulated deficit, a going concern qualification from auditors, and a NYSE American non-compliance notice. The foreclosure of its patent portfolio and significant revenue decline highlight operational distress. While strategic pivots and capital raises are underway, the immediate financial health is critical and highly concerning.

Positives

  • Stockholders approved the issuance of shares on conversion of March and April 2025 Indigo Notes in excess of the NYSE Share Cap on July 9, 2025.
  • Stockholders approved issuances of shares pursuant to the SEPA in excess of the SEPA Share Cap on July 9, 2025.
  • NYSE American accepted the company's Compliance Plan on July 22, 2025, granting a plan period until October 29, 2026, to regain compliance.
  • All long-term, secured indebtedness has been eliminated through conversion of outstanding indebtedness and the foreclosure sale of the patent portfolio in March 2025.
  • The company is pursuing a 'Transformation Plan' to diversify its asset base through strategic acquisitions and investments in defense-tech and operational resilience SaaS.
  • Formation of Tekne US JV is expected to generate revenue of up to approximately $7.5 million from open orders and backlog while Golden Power review is completed.
  • The company entered into a convertible facility with Supply@ME Capital Plc (SYME) to loan SYME up to $5.15 million, potentially leading to a controlling interest in SYME.

Negatives

  • The company will not receive any proceeds from the sale of the 25,938,157 shares by the selling stockholders.
  • Significant dilution risk for existing stockholders due to future resales and issuances of Common Stock, including up to 25,938,157 shares in this filing, 50,000,000 shares under SEPA, and 40,700,408 shares under a prior resale registration.
  • The company is an early-stage company with a history of losses, incurring net losses of $34.5 million in 2024 and $28.8 million for the six months ended June 30, 2025.
  • Accumulated deficit reached $150.2 million as of June 30, 2025.
  • Revenue declined drastically from $2.08 million in 2023 to $152,127 in 2024, and was nil in H1 2025.
  • The company has substantial doubt about its ability to continue as a going concern.
  • Lack of funding led to employee furloughs in Q3/Q4 2024 and employee resignations.
  • The company defaulted on its lease, resulting in a default judgment of $409,278 (plus 10% annual interest from March 2025) and the write-down of inventory, property, and equipment to zero in Q1 2025.
  • The company's patent portfolio was foreclosed upon and transferred to senior secured lenders in March 2025.
  • The company is obligated to redeem all outstanding Series A Preferred Stock for $10.00 per share as of January 31, 2025, but does not believe it currently has legally available funds to pay this amount ($23,889,050).
  • The company has identified material weaknesses in its internal control over financial reporting.
  • The company's management has limited experience operating a public company.
  • The company faces potential antitrust and other legal challenges related to acquisitions.
  • The company's Executive Chairman, Alessandro Zamboni, is the founder and current CEO of SYME, raising potential related-party transaction concerns for the SYME strategic investment.
  • The proposed investment in the SaaS startup (part of TCEI acquisition) involves the Executive Chairperson owning a controlling interest, requiring independent board member negotiation and stockholder approval.
  • The company is subject to a legal claim from J.H. Darbie for advisory and finders fees, which the company intends to defend vigorously as services were allegedly not provided.

Risks

  • Future resales and/or issuances of shares of Common Stock, including pursuant to this prospectus, may cause the market price of shares to drop significantly and may dilute stockholders.
  • An early-stage company with a history of losses; has not been profitable historically and may not be able to achieve profitability in the future.
  • Will require additional capital to finance operations and implement business plan and strategy, and if unable to raise such capital when needed, or on acceptable terms, that could have a material adverse effect on ability to meet financial obligations and support continued growth and development.
  • To achieve growth objectives, management will rely on a rapid succession of strategic acquisitions, investments and procurement arrangements, the pace and scope of which may have the potential to adversely affect the day-to-day operation of business, and cash flows, financial condition and results of operations.
  • Growth objectives require substantial capital that may be unable to obtain, or may only obtain at a cost or under terms that adversely affect cash flows, financial condition and results of operations.
  • May have difficulty managing growth in business, which could adversely affect financial condition.
  • May experience difficulties in integrating acquired assets into business and in realizing the expected benefits of an acquisition.
  • Products and services involve a lengthy sales and installation cycle, and if fail to close sales on a regular and timely basis it could harm business. The long sales cycles for products may cause to incur significant expenses without offsetting revenues.
  • If fail to meet customers price expectations, demand for products could be negatively impacted.
  • Anticipate deriving a portion of revenue from government entities, and significant changes in the contracting or fiscal policies of such government entities could have an adverse effect on business.
  • Highly dependent on key executives and if unable to attract and retain key employees and hire qualified management, technical, engineering, and sales personnel, ability to compete and successfully grow business could suffer.
  • Expectations and targets regarding the times when products will launch depend in large part upon assumptions, estimates, measurements, testing, analyses and data developed and performed, which if incorrect or flawed, could have a material adverse effect on actual operating results and performance.
  • Expect to incur significant research and development expenses and devote substantial resources to commercializing new products, which could increase losses and negatively impact ability to achieve or maintain profitability.
  • Insurance coverage may not adequately protect from harm or losses may suffer.
  • There is no assurance that will be able to execute on business model.
  • Expanding operations internationally will subject to a variety of risks and uncertainties that could adversely affect business and operating results.
  • Uses novel technologies, and potential customers may be hesitant to make a significant investment in technology or switch from the technology they are currently using.
  • Market is characterized by rapid technological changes demanding a significant investment in research and development, and, if fail to address changing market conditions, business will be harmed.
  • Litigation, regulatory actions, and compliance issues could subject to significant fines, penalties, judgments, remediation costs, negative publicity, and requirements resulting in increased expenses.
  • Laws, regulations, and rules relating to privacy, information security, and data protection could significantly increase costs and adversely affect business opportunities.
  • Could be negatively impacted by various export controls, tariffs and trade and economic sanctions laws and regulations that may change due to diplomatic and political considerations outside of control.
  • Could be liable for environmental damages from operations, which could negatively impact reputation, business, and operating results.
  • May be unable to protect, defend, maintain, or enforce intellectual property rights for the intellectual property on which business depends, including against existing or future competitors. Failure to protect defend, maintain and enforce that intellectual property could result in competitors offering similar products, potentially adversely affecting growth and success.
  • May be subject to third-party claims of infringement, misappropriation or other violations of intellectual property rights, or other claims challenging agreements related to intellectual property, which may be time consuming and costly to defend, and could result in substantial liability.
  • May not be able to protect intellectual property rights throughout the world.
  • May be subject to claims that or employees have misappropriated the intellectual property of a third party or are in breach of non-competition or non-solicitation agreements with competitors.
  • If unable to protect the confidentiality of proprietary information, business may be harmed.
  • Cyber-attacks and other disruptions, security breaches, and incidents could have an adverse effect on business, harm reputation, and expose to liability.
  • Natural disasters, unusual weather conditions, epidemic outbreaks, terrorist acts, and political events could disrupt business. Interruption or failure of infrastructure could hurt ability to effectively perform daily operations and provide and produce products and services, which could harm operating results.
  • Received a Notice of Noncompliance from the NYSE American and the NYSE American may delist securities from trading on its exchange, which could limit investors ability to make transactions in securities and subject to additional trading restrictions.
  • Had to restate previously issued consolidated financial statements and identified material weaknesses in internal control over financial reporting. If unable to develop and maintain effective internal control over financial reporting, may not be able to accurately report financial results in a timely manner, which may adversely affect investor confidence and business.
  • Management has limited experience in operating a public company.
  • The redemption of Preferred Stock may require a significant amount of cash and may result in adverse tax consequences.
  • Future sales of substantial amounts of Common Stock in the public markets, or the perception that such sales could occur, could cause the market price of Common Stock to drop significantly, even if business is doing well, and certain selling securityholders still may receive significant proceeds.
  • Outstanding convertible notes, preferred stock, and warrants contain anti-dilution protection, which may cause significant dilution to stockholders.
  • May redeem unexpired Public Warrants prior to their exercise at a time that is disadvantageous to you, thereby making Public Warrants worthless.
  • Common Stock is subordinated to Preferred Stock.
  • No current plans to pay cash dividends on Common Stock or Preferred Stock for the foreseeable future, so may not receive any return on investment unless sell shares for a price greater than that which originally paid.

Future Outlook

The company anticipates continued net losses for the foreseeable future as it implements its "Transformation Plan" to diversify its asset base through strategic acquisitions and investments in defense-tech and operational resilience SaaS. The plan involves shifting the laser business focus to licensing and joint development, outsourcing manufacturing, and securing additional capital through various financing agreements, including a Standby Equity Purchase Agreement for up to $100 million. The company aims to regain compliance with NYSE American listing standards by October 29, 2026, through these strategic initiatives, but acknowledges that these transactions are subject to regulatory and stockholder approvals and may not achieve anticipated results.

Management Comments

  • We intend to diversify our asset base by investing in other businesses that include potential synergies with our existing business.
  • We are adjusting our laser business to focus on licensing and joint development within specific verticals, as described below.
  • We anticipate coordinating future research and development through our partnerships and key subsidiaries.
  • We anticipate significant changes to our sales and marketing programs in the future to align with our licensing and joint development strategy, along with our onboarding of key acquisitions.
  • We view our human capital investments as crucial for our success.
  • Unless we are able to implement our Transformation Plan described below, these factors raise substantial doubt about our ability to continue as a going concern.
  • The Company believes that, upon consummation of certain of the transactions that it has recently announced, it will be able to regain compliance.
  • However, such transactions are subject to regulatory approvals, stockholder approval, and other closing conditions and, as a result, may not be consummated. Even if consummated, such transactions may not achieve the anticipated results or benefits to the Company.

Industry Context

The company is transitioning from a focus on high-power blue laser technology, a market characterized by rapid technological changes and significant competition from established players like Coherent, nLight, and IPG Photonics, as well as emerging green laser technologies. Following the foreclosure of its patent portfolio, Nuburu is pivoting to a licensing and joint development model within specific verticals, notably the defense industry. This strategic shift aims to diversify its asset base and expand into new, potentially synergistic areas like defense-tech and operational resilience SaaS, moving away from direct manufacturing and traditional laser product sales. This indicates a response to competitive pressures and financial constraints in its legacy market, seeking growth in adjacent, high-value sectors.

Comparison to Industry Standards

  • The filing does not provide specific comparable companies, projects, or results to assess against global benchmarks. It primarily discusses the company's internal strategic shift and financial performance.
  • The company acknowledges that its historical laser system industry has "significant price and technological competition" from "mature competitors" (Coherent, Inc., nLight, Inc., IPG Photonics Corporation, Laserline GmbH, Lumentum Holdings Inc., Raycus Fiber Laser Technologies Co., Ltd. and Trumpf SE + Co. KG) which have "longer operating histories, significantly greater financial and operational resources, and name recognition." This implies Nuburu is not meeting industry standards set by these larger, more established players in its legacy business.
  • The pivot to licensing and joint development in defense, and acquisitions in defense-tech and SaaS, suggests an attempt to find new market niches where it can establish a competitive advantage, rather than directly competing with the established laser manufacturers on their terms.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Executive ChairmanRon NicolAlessandro ZamboniJanuary 2025Part of governance changes related to the Transformation Plan.
Chief Executive Officer and DirectorBrian KnaleyNAJanuary 31, 2025Resignation.
DirectorJohn BoltonNAApril 30, 2024Resignation.
DirectorDaniel HirschNAJanuary 31, 2025Resignation.
DirectorKristi HummelNAOctober 21, 2024Resignation.
DirectorLily Yan HughesNAOctober 21, 2024Resignation.
DirectorElizabeth MoraNAJanuary 31, 2025Resignation.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Bylaws AmendmentAmended and Restated Bylaws of the Company, as amended by the Amendment thereto, dated November 12, 2024.November 12, 2024Changes to internal operating rules and procedures.
Certificate of Incorporation AmendmentAmended and Restated Certificate of Incorporation, as amended by the Amendment thereto, filed on June 24, 2024, and the Amendment thereto, filed on July 22, 2025.June 24, 2024, July 22, 2025Changes to the company's fundamental governing document, including an increase in authorized shares.
Authorized Shares IncreaseStockholders approved an amendment to increase the number of authorized shares of Common Stock from 250,000,000 to 900,000,000.July 9, 2025Allows for significant future equity issuances, potentially increasing dilution for existing shareholders.
Reverse Stock Split AuthorizationStockholders approved the effectuation of one or more reverse stock splits during the 12 months following July 9, 2025.July 9, 2025Aims to increase share price, potentially to maintain NYSE American listing, but can reduce liquidity and may not improve underlying value.
Share Issuance Cap ApprovalStockholders approved the issuance of Common Stock in excess of 19.99% of outstanding common stock for Indigo Capital Convertible Notes and SEPA.July 9, 2025Enables larger capital raises through convertible notes and SEPA without further stockholder approval for these specific transactions, but increases potential for dilution.
Non-Public Offering Discount ApprovalStockholders approved the issuance of up to $100 million of securities in one or more non-public offerings with a maximum discount of up to 30% to market price.July 9, 2025Provides flexibility for future capital raises but allows for significant discounts, which can be dilutive to existing shareholders.
Internal Control Weaknesses RemediationIdentified material weaknesses in internal control over financial reporting; plans to hire additional qualified personnel and adopt sufficient written policies and procedures.Ongoing (fiscal year ending December 31, 2025)Aims to improve financial reporting accuracy and compliance, but remediation is time-consuming and costly with no assurance of immediate success.

Legal Proceedings

  • CFGI, LLC obtained a default judgment in March 2025 for $86,826 through the Superior Court of the Commonwealth of Massachusetts.
  • FICTIV, Inc. obtained a default judgment through the Superior Court of California on January 30, 2025, in the amount of $197,899, which was subsequently settled by the company.
  • The Landlord obtained a default judgment in April 2025 for $409,278, which accrues interest at a rate of 10% per annum beginning in March 2025 until paid in full, through the Arapahoe County Colorado District Court.
  • J.H. Darbie initiated a legal claim regarding advisory and finders fees, which the company intends to defend vigorously as services were allegedly not provided.

Related Party Transactions

  • Indigo Capital LP: Issued multiple unsecured convertible notes to Indigo Capital LP in March, April, July, and August 2025, for capital infusions and debt extinguishments. Indigo Capital LP is a selling stockholder.
  • S.F.E. Equity Investments SARL (SFE EI): Entered into a letter agreement on January 13, 2025, for financing and the Transformation Plan. Agreed to issue 6,086,957 shares of common stock as consideration for escrowing $4.2 million in assets to guarantee TCEI acquisition performance. SFE EI is a beneficial owner (>5%).
  • Alessandro Zamboni (Executive Chairman): Owns a controlling interest in the SaaS startup targeted for acquisition (part of TCEI acquisition). Loaned $900,000 of cash proceeds from the TCEI acquisition back to the company for working capital in May 2025. Founder and owner of The AvantGarde Group (TAG), which advanced $545,000 to the company in January 2025 (TAG Promissory Note). Founder and current Chief Executive Officer of Supply@ME Capital Plc (SYME), with which the company entered into a convertible facility.
  • The AvantGarde Group (TAG): Issued a $545,000 promissory note to TAG in January 2025, replacing a previously recorded shareholder advance.
  • Wilson-Garling 2023 Family Trust: Held $5,138,055 in Senior Convertible Notes as of December 31, 2024. Thomas J. Wilson, an affiliate, was a Legacy Nuburu director.
  • David Seldin: Held $762,211 in Junior Notes and $1,233,133 in Senior Convertible Notes as of December 31, 2024. Was a Legacy Nuburu director and sole manager of Anzu SPVs.
  • Eunomia, LP: Held $1,100,000 in Junior Notes and $1,027,611 in Senior Convertible Notes as of December 31, 2024. Ron Nicol, manager of Eunomia, LP, was the Executive Chairman until January 2025.
  • CST Global LLC: Held $220,000 in Junior Notes and $100,000 in Senior Convertible Notes as of December 31, 2024. David Michael, an affiliate, was a Legacy Nuburu director.
  • Curtis N Maas Revocable Trust: Held $102,761 in Senior Convertible Notes as of December 31, 2024. Curtis Maas, an affiliate, was a Legacy Nuburu director.
  • Ron Nicol: Paid director and officer insurance premiums of approximately $1.5 million on behalf of the company, which the company is obligated to repay without interest.
  • Anzu Partners: Provided services to Legacy Nuburu, reimbursed for out-of-pocket expenses, received $500,000 payment and a warrant for 500,000 shares of Preferred Stock in connection with the Business Combination.
  • Lincoln Park Capital Fund, LLC: Company may direct Lincoln Park to purchase up to $100 million of Common Stock.
  • Phoenix MGMT Consulting LLC: Entered into a consulting agreement on March 1, 2025, for ongoing services in exchange for 1,000,000 shares of Common Stock upon execution and quarterly issuances of Common Stock valued at $25,000.

Stakeholder Impact

  • Shareholders: Face significant dilution risk from current and future share issuances (resale, SEPA, convertible notes, warrants, equity awards). Market price volatility is expected. Common Stock is subordinated to Preferred Stock. No anticipated cash dividends.
  • Employees: Experienced furloughs and resignations due to funding issues. The company needs to attract and retain key personnel for its new strategy. Stock-based compensation is a component of executive and employee compensation.
  • Customers: Legacy products had lengthy sales and installation cycles. The new business strategy focuses on licensing and joint development, potentially changing customer relationships. Government entities are anticipated to be a source of revenue.
  • Suppliers: Potential impact from liquidity constraints and changes in manufacturing strategy (outsourcing). Purchase commitments exist.
  • Creditors: Secured lenders foreclosed on the patent portfolio to extinguish debt. Unsecured creditors (like the landlord and CFGI, FICTIV) have obtained default judgments. Silverback Capital settled claims for shares. Preferred stockholders are owed redemption but funds are unavailable.

Next Steps

  • Regain compliance with NYSE American continued listing standards by October 29, 2026.
  • Negotiate and execute definitive agreements for the Tekne acquisition.
  • Obtain regulatory and stockholder approvals for the Tekne acquisition.
  • Complete the First Stage (3% equity interest) of the Tekne acquisition in September 2025.
  • Complete the Second Stage (remaining 67% interest) of the Tekne acquisition by the end of 2025.
  • Assist with financing up to EUR 40 million for Tekne's working capital needs.
  • Form a U.S.-based joint venture (Tekne US JV) with Tekne.
  • Develop new products in the defense sector for the Americas market through Tekne US JV.
  • Manufacture and sell existing products in the Americas through Tekne US JV.
  • Manage direct sales to non-Italian Tekne clients through Tekne US JV.
  • Convert amounts outstanding under the SYME convertible facility into ordinary shares of SYME, subject to approvals.
  • Pursue a lease for a replacement facility more appropriate for the new business strategy.
  • Recruit and retain additional management, human resources, accounting, finance, technical, engineering, and sales personnel.
  • Implement remediation measures for identified material weaknesses in internal control over financial reporting.
  • Continue to seek additional funds through public or private equity offerings, debt financings, joint ventures, partnerships, collaborations, and licensing arrangements.
  • Address outstanding obligations, including overdue payables and preferred stock redemption.

Key Dates

DateDescription
July 21, 2020Nuburu, Inc. (f/k/a Tailwind Acquisition Corp.) originally incorporated in Delaware.
September 9, 2020Consummated initial public offering (IPO).
December 10, 2021Legacy Nuburu entered into an Amended and Restated Investors Rights Agreement and Amended and Restated Right of First Refusal and Co-sale Agreement.
December 10, 2021Legacy Nuburu entered into an Amended and Restated Voting Agreement.
December 2021 January 2022Legacy Nuburu sold an aggregate of 1,166,372 shares of Series C Preferred Stock for approximately $5.8 million.
August 5, 2022Business Combination Agreement signed between the Company, Merger Sub, and Legacy Nuburu.
August 30, 2022Legacy Nuburu entered into Services Agreement with Anzu Partners.
September 7, 2022Tailwind held a special meeting of stockholders to amend the Pre-Closing Tailwind Certificate of Incorporation to extend the Termination Date.
September 9, 2022Tailwind issued an unsecured promissory note of up to $750,000 to the Sponsor.
November 2, 2022Amendment to Registration Rights and Lock-Up Agreement entered.
November 22, 2022Sponsor Letter Agreement Amendment entered.
November 28, 2022Anzu Designee Letter Agreement entered.
November 28, 2022Second Amendment to Preferred Stock Sale Option Agreement entered.
December 2, 2022Employment agreement with Brian Knaley (former CEO) effective.
December 2, 2022Amended and restated employment agreement with Brian Faircloth (COO) effective.
December 8, 2022Anzu Resolutions Letter Agreement entered.
January 25, 2023Sponsor entered into Share Transfer Agreement.
January 31, 2023Consummated business combination with Legacy Nuburu, changed name to Nuburu, Inc. (Closing Date).
January 31, 2023Amended and Restated Sponsor Support and Forfeiture Agreement became effective.
January 31, 2023Amended and Restated Letter Agreement became effective.
January 31, 2023Second Amendment to Registration Rights and Lock-Up Agreement became effective.
January 31, 2023Third Amendment to Registration Rights and Lock-Up Agreement became effective.
January 31, 2023Preferred Stock became mandatorily redeemable.
March 10, 2023Third Amendment to Preferred Stock Sale Option Agreement entered.
March 10, 2023Fourth Amendment to Registration Rights and Lock-Up Agreement entered.
May 19, 2023Ake Almgren resigned as a director.
June 12, 2023Company entered into Note and Warrant Purchase Agreements (Senior Convertible Note Purchase Agreements).
June 16, 2023Company entered into Note and Warrant Purchase Agreements (Senior Convertible Note Purchase Agreements) and Registration Rights and Lock-Up Agreement.
November 1, 2023Brian Knaley appointed CEO, salary increased to $410,000.
November 13, 2023Company entered into Junior Note Purchase Agreements.
December 12, 2023NYSE American notified the company of non-compliance and delisting proceedings for Public Warrants.
January 1, 2024Brian Faircloth's amended and restated employment agreement effective.
February 22, 2024Stockholders approved reverse stock split.
April 2024Chief Marketing and Sales Officer departed.
May 1, 2024Company entered into Pre-Funded Warrant Purchase Program.
July 23, 2024Company effected a 1-for-40 reverse stock split.
July 29, 2024NYSE American notified the company of resolved listing deficiency and lifted trading suspension.
August 2, 2024Common Stock re-commenced trading on NYSE American.
August 6, 2024Company entered into subordinated convertible note agreement with Esousa Group Holdings LLC (August 2024 Convertible Notes).
August 19, 2024Company entered into subordinated convertible note agreement with Esousa Group Holdings LLC (Additional August 2024 Convertible Notes).
October 1, 2024Company entered into Master Agreement with Liqueous LP.
October 24, 2024Underwriters over-allotment option expired unexercised, 269,607 Founder Shares forfeited.
October 2024Company entered into unsecured promissory note with Liqueous for $1,053,824.
November 12, 2024Bylaws amended.
December 16, 2024Lead Investor issued notice of default and acceleration for Senior Convertible Notes.
December 28, 2024Annual option awards granted to directors.
January 13, 2025Company entered into letter agreement with SFE EI for financing and Transformation Plan.
January 14, 2025Company entered into settlement and mutual release agreement with Liqueous.
January 30, 2025FICTIV, Inc. obtained default judgment of $197,899 against the company.
January 31, 2025Brian Knaley resigned as CEO and director.
February 2025Company amended Settlement with Liqueous.
February 17, 2025Company entered into amendment to Settlement with Liqueous.
February 19, 2025Company entered into commitment letter with Trumar Capital LLC for acquisitions.
February 28, 2025Company entered into share exchange agreement and master distribution agreement with HUMBL, Inc. (subsequently terminated).
March 1, 2025Company and Phoenix MGMT Consulting LLC entered into a consulting agreement.
March 3, 2025Company issued convertible notes to Indigo Capital LP for $1,500,000 capital infusion and extinguishment of August 2024 Convertible Notes.
March 5, 2025Secured lenders concluded foreclosure sale, extinguishing Junior and Senior Convertible Notes.
March 2025CFGI, LLC obtained default judgment of $86,826 against the company.
March 31, 2025Company entered into Joint Pursuit Agreement with Tekne.
April 2025Landlord obtained default judgment of $409,278 (plus 10% annual interest from March 2025) against the company.
April 15, 2025Company amended Settlement with Liqueous.
April 22, 2025Company issued convertible notes to Indigo Capital LP for $1,350,000 capital infusion and extinguishment of existing unsecured promissory note.
April 29, 2025Company received Notice of Noncompliance from NYSE Regulation.
May 13, 2025Company entered into Securities Purchase Agreement with 1800 Diagonal Lending LLC (Diagonal Note).
May 13, 2025Company entered into Securities Purchase Agreement with Boot Capital LLC (Boot Note).
May 29, 2025Company submitted Compliance Plan to NYSE Regulation.
May 30, 2025Company entered into Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD.
May 30, 2025Company executed an amendment to the Business Loan and Security Agreement with Agile.
June 3, 2025Company entered into transactions with Brick Lane Capital Management Limited for preferred stock transfer and capital infusion.
June 9, 2025Company filed First SEPA Form S-1.
June 18, 2025Company entered into transactions with Bomore Opportunity Group Ltd for preferred stock transfer and capital infusion.
June 25, 2025Company entered into transactions with Torcross Capital LLC for preferred stock transfer and capital infusion.
June 30, 2025Bomore provided conversion notice for $1,050,000 principal under Bomore Exchange Convertible Note.
June 30, 2025Company entered into securities purchase agreement for Yorkville Promissory Note (closed in July 2025).
July 1, 2025Shares available for grant under 2022 Plan and ESPP increased.
July 9, 2025Stockholders approved increase in authorized Common Stock, reverse stock splits, and issuance of shares in excess of 19.99% cap for Indigo Capital Convertible Notes and SEPA.
July 15, 2025Company issued remaining 1,332,623 shares of Common Stock to SEPA Investor.
July 16, 2025Company issued July Indigo Capital Convertible Note for $150,000 capital infusion.
July 17, 2025Company and Silverback Capital Corporation agreed to settle outstanding claims for $5,662,479 in Common Stock.
July 21, 2025Company entered into Securities Purchase Agreement with Diagonal (July Diagonal Convertible Note).
July 22, 2025NYSE American accepted Compliance Plan, granting period through October 29, 2026.
July 22, 2025Company filed Certificate of Amendment to Amended and Restated Certificate of Incorporation, increasing authorized shares to 950,000,000.
July 24, 2025First SEPA Form S-1 declared effective.
July 30, 2025Silverback settlement approved by state court.
August 18, 2025Company issued August Indigo Capital Convertible Note for $225,000 capital infusion.
August 20, 2025Last quoted sale price for Common Stock was $0.1630 per share.
August 27, 2025Nuburu executed binding commitment letter with Tekne shareholders, modifying acquisition terms.
August 29, 2025S-1 Registration Statement filed.
September 2025Expected acquisition of 3% equity interest in Tekne (First Stage).
October 29, 2026Compliance deadline for NYSE American continued listing standards.
End of 2025Expected acquisition of remaining 67% interest in Tekne (Second Stage).

Recommendation

strong sell

The company is in severe financial distress, evidenced by recurring and increasing net losses, a substantial accumulated deficit, and a going concern qualification from its auditors. The NYSE American has issued a non-compliance notice, and the company's core patent portfolio was foreclosed upon. Revenue has plummeted to nil in the most recent interim period. While the company is attempting a strategic pivot and has secured some financing, the scale of its financial challenges, the high dilution risk from ongoing and planned capital raises, and the uncertainty of successful execution of its new business model make it a highly speculative and risky investment. The current share price of $0.1630 reflects this distress, and further downside is probable given the fundamental issues and the potential for continued dilution and operational hurdles.

Keywords

Nuburu Inc., BURU, SEC S-1 filing, Common Stock resale, Convertible notes, Dilution, NYSE American non-compliance, Going concern, Blue laser technology, Defense-tech, SaaS, Strategic acquisitions, Capital raise, Financial losses, Intellectual property foreclosure, Risk factors, Corporate governance, Financial reporting, Market volatility

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.